Carlos Carmona-Fontaine

Carlos Carmona-Fontaine

Auto-generated profile, based on publicly available information

Carlos Carmona-Fontaine

Center for Genomics and Systems Biology, Department of Biology, New York University, New York City, NY, United States of America

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
CCCarlos Carmona-Fontaine
Carlos Carmona-Fontaine
MDMaxime Deforet
Maxime Deforet
LALeila Akkari
Leila Akkari
CTCraig B. Thompson
Craig B. Thompson
JJJohanna A. Joyce
Johanna A. Joyce
JXJoao B. Xavier
Joao B. Xavier
Significance: Cancers appear as disordered mixtures of different cells, which is partly why they are hard to treat. We show here that despite this chaos, tumors show local organization that emerges from cellular processes common to most cancers: the altered metabolism of cancer cells and the interactions with stromal cells in the tumor microenvironment. With a multidisciplinary approach combining experiments and computer simulations we revealed that the metabolic activity of cancer cells produces gradients of nutrients and metabolic waste products that act as signals that cells use to know their position with respect to blood vessels. This positional information orchestrates a modular organization of tumor and stromal cells that resembles embryonic organization, which we could exploit as a therapeutic target.

13 March 2023 in Cancer Research
Verified
Journal Article
Closed access
PDF file
SSSimon Schwörer
Simon Schwörer
FCFrancesco V. Cimino
Francesco V. Cimino
MRManon Ros
Manon Ros
KTKaloyan M. Tsanov
Kaloyan M. Tsanov
CNCharles Ng
Charles Ng
CTCraig B. Thompson
Craig B. Thompson
Cancer-associated fibroblasts (CAF) are a major cell type in the stroma of solid tumors and can exert both tumor-promoting and tumor-restraining functions. CAF heterogeneity is frequently observed in pancreatic ductal adenocarcinoma (PDAC), a tumor characterized by a dense and hypoxic stroma that features myofibroblastic CAFs (myCAF) and inflammatory CAFs (iCAF) that are thought to have opposing roles in tumor progression. While CAF heterogeneity can be driven in part by tumor cell–produced cytokines, other determinants shaping CAF identity and function are largely unknown. In vivo, we found that iCAFs displayed a hypoxic gene expression and biochemical profile and were enriched in hypoxic regions of PDAC tumors, while myCAFs were excluded from these regions. Hypoxia led fibroblasts to acquire an inflammatory gene expression signature and synergized with cancer cell–derived cytokines to promote an iCAF phenotype in a HIF1α-dependent fashion. Furthermore, HIF1α stabilization was sufficient to induce an iCAF phenotype in stromal cells introduced into PDAC organoid cocultures and to promote PDAC tumor growth. These findings indicate hypoxia-induced HIF1α as a regulator of CAF heterogeneity and promoter of tumor progression in PDAC. Significance: Hypoxia in the tumor microenvironment of pancreatic cancer potentiates the cytokine-induced inflammatory CAF phenotype and promotes tumor growth. See related commentary by Fuentes and Taniguchi, p. 1560

11 November 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
CCCarlos Carmona-Fontaine
Carlos Carmona-Fontaine
VBVanni Bucci
Vanni Bucci
LALeila Akkari
Leila Akkari
MDMaxime Deforet
Maxime Deforet
JJJohanna A. Joyce
Johanna A. Joyce
JXJoao B. Xavier
Joao B. Xavier
Significance: Cancer cells undergo dramatic metabolic alterations, such as the Warburg effect where glucose is consumed independently of oxygen, leading to high lactic acid production. Although these alterations can give growth advantages to cancer cells, they have a profound effect in the extracellular environment, and thus it is not clear how they affect healthy cells. Here we show that lactic acid accumulation can impair the survival of tumor-associated macrophages. Using a multidisciplinary combination of computational and experimental methods, we show that this decreased survival can lead to spatial patterns of macrophage localization that resemble how tumor-associated macrophages distribute in real tumors. Spatial patterns can potentiate tumor growth, and thus understanding how they are formed may bring therapeutic insights.

14 January 2014 in Soft Matter
Verified
Journal Article
Closed access
PDF file
MDMaxime Deforet
Maxime Deforet
DDDave van Ditmarsch
Dave van Ditmarsch
CCCarlos Carmona-Fontaine
Carlos Carmona-Fontaine
JXJoao B. Xavier
Joao B. Xavier
Pseudomonas aeruginosa is a monoflagellated bacterium that can use its single polar flagellum to swim through liquids and move collectively over semisolid surfaces, a behavior called swarming. Previous studies have shown that experimental evolution in swarming colonies leads to the selection of hyperswarming bacteria with multiple flagella. Here we show that the advantage of such hyperswarmer mutants cannot be explained simply by an increase in the raw swimming speed of individual bacteria in liquids. Cell tracking of time-lapse microscopy to quantify single-cell swimming patterns reveals that both wild-type and hyperswarmers alternate between forward and backward runs, rather than doing the run-and-tumble characteristic of enteric bacteria such as E. coli. High-throughput measurement of swimming speeds reveals that hyperswarmers do not swim faster than wild-type in liquid. Wild-type reverses swimming direction in sharp turns without a significant impact on its speed, whereas multiflagellated hyperswarmers tend to alternate fast and slow runs and have wider turning angles. Nonetheless, macroscopic measurement of swimming and swarming speed in colonies shows that hyperswarmers expand faster than wild-type on surfaces and through soft agar matrices. A mathematical model explains how wider turning angles lead to faster spreading when swimming through agar. Our study describes for the first time the swimming patterns in multiflagellated P. aeruginosa mutants and reveals that collective and individual motility in bacteria are not necessarily correlated. Understanding bacterial adaptations to surface motility, such as hyperswarming, requires a collective behavior approach.

8 July 2019 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
SVSantosha A. Vardhana
Santosha A. Vardhana
PAPaige K. Arnold
Paige K. Arnold
BRBess P. Rosen
Bess P. Rosen
YCYanyang Chen
Yanyang Chen
BCBryce W. Carey
Bryce W. Carey
LFLydia W. S. Finley
Lydia W. S. Finley

6 July 2018 in Disease Models & Mechanisms
Verified
Journal Article
Open access
PDF file
SHSpencer A. Hobson-Gutierrez
Spencer A. Hobson-Gutierrez
CCCarlos Carmona-Fontaine
Carlos Carmona-Fontaine
The extracellular space of solid tumors ranges from being well-nurtured to being completely ischemic and can serve as a source of intratumoral heterogeneity, determining the behavior and molecular profiles of malignant and stromal cells. Here, we discuss how the metabolic tumor microenvironment modulates the phenotypes of the immune cells that infiltrate tumors, with an emphasis on tumor-associated macrophages. These cells constitute a diverse population that has pro-tumoral and anti-inflammatory properties, and are likened to anti-inflammatory ‘M2’ macrophages. Recent findings show how different metabolic microenvironments specify an array of phenotypic changes in macrophages. In tumors, extracellular metabolite levels vary predictably according to proximity to the vasculature, and phenotypic changes in tumor-associated macrophages and in other immune cells are also predictable. We speculate that this ‘metabolic axis’ of macrophage polarization modulates – and is modulated by – the response to inflammatory cues, creating a wide variety of possible phenotypic states. Understanding how extracellular metabolites influence cell phenotypes allows us to predict how tumor-associated macrophages and other tumor cells might change, with the aim of harnessing this predictability for therapy. Overall, we describe an emerging picture in which chemokines, growth factors and the metabolic tumor microenvironment act together to determine the phenotypes of tumor-infiltrating immune cells.